Takeda Pharmaceutical Co Ltd
F:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
IPD Group Ltd
F:IS6
|
AU |
|
V
|
Vinci SA
DUS:SQU
|
FR |
|
L
|
Liveramp Holdings Inc
F:XIM
|
US |
|
S
|
Stryker Corp
XMUN:SYK
|
US |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 28.95 EUR with a low forecast of 24.26 EUR and a high forecast of 36.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
28.95
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 28.95 EUR with a low forecast of 24.26 EUR and a high forecast of 36.9 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.
